# Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela

Clinical trial · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

- Archive id: nct:NCT04642339
- Published: 2020-11-24
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT04642339
- Source URL: https://clinicaltrials.gov/study/NCT04642339
- Provenance: clinicaltrials

## Abstract

Randomized, double-blind, placebo controlled clinical trial of immunogenicity, safety and efficacy of the Gam-COVID-Vac combined vector vaccine against the SARS-CoV-2-induced coronavirus infection in adults.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- acronym: VENEZUELA
- status: UNKNOWN
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 2000
- sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- conditions: Covid19
- interventions: BIOLOGICAL: Gam-COVID-Vac; BIOLOGICAL: Placebo
- start date: 2020-11-01
- start date type: ESTIMATED
- primary completion date: 2021-10-01
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.